Treatment of type 2 diabetes with incretin-based therapies

ArticleinThe Lancet 373(9662):438-9 · October 2008with1 Read
Impact Factor: 45.22 · DOI: 10.1016/S0140-6736(08)61247-7 · Source: PubMed